193 filings
Page 4 of 10
8-K
ok8ic98
6 May 20
Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
5:01pm
8-K
is9l tlhofwrjnyei
29 Apr 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:49pm
8-K
wc1ri
13 Mar 20
Tenax Therapeutics Announces $2.75 Million Registered Direct Offering Priced At-the-Market
8:16am
8-K
vuhhfmq2lmhii
13 Jan 20
Other Events
8:07am
8-K/A
7azvc35wfew5n
8 Nov 19
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
m2smzut46u lr4ylysc
14 Jun 19
Submission of Matters to a Vote of Security Holders
4:32pm
8-K
mwtn58 h43tmrx
11 Dec 18
Tenax Therapeutics Announces Closing of
4:05pm
8-K
outa7u20ee
13 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
9s2419 2o
5 Jun 18
Tenax Therapeutics Announces Appointment of
4:45pm
8-K
d1l8s9r0 9rk9b2rap7
14 Mar 18
Other Events
12:00am
8-K
9cbj4s4lm1nbqi6zcr8t
23 Feb 18
Tenax Therapeutics Announces Reverse Stock Split
12:00am
8-K
tcv9qqc ga6pzuhgk
15 Feb 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
c6pjy5ug
12 Sep 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
ryb s6iw5
28 Jul 17
Tenax Therapeutics Provides Regulatory Update on Levosimendan
12:00am
8-K
q33mqp
15 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
flm0gdc
7 Apr 17
Tenax Therapeutics Announces Review of Strategic Alternatives and Business Update
12:00am
8-K
u0szp 2uk
17 Mar 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
df2zkw vc
31 Jan 17
Tenax Therapeutics Announces Top-Line Results From
12:00am
8-K
1e1705
16 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
qtl wvgapuf
19 May 16
Tenax Therapeutics Announces First Quarter 2016 Financial Results and Provides Corporate Update
12:00am